Older patients benefit from lower doses of sunitinib in renal cell carcinoma
10 Nov 2014
Older patients benefit from lower doses of sunitinib in renal cell carcinoma
Age and chemotherapy: risk factors versus benefit?
"Cancer buddies" provide empowerment for the elderly
Prescribing adjuvant chemotherapy in elderly patients
Adjuvant chemotherapy in elderly ER HER2- breast cancer patients
Hip fracture complications of prostate cancer treatment
What is 'frailty' in elderly cancer patients?
Implications of targeted cancer therapies for elderly patients
Geriatric oncology challenges in Latin America
Comorbidity, complex cancers and the elderly
Novel capsule medication prevents nausea, vomiting in chemotherapy
Ipilimumab extends relapse-free survival in resectable melanoma